Literature DB >> 11561167

Class A scavenger receptors, macrophages, and atherosclerosis.

M F Linton1, S Fazio.   

Abstract

The scope of this review is to discuss the new advances in our understanding of the role of scavenger receptor class A in the initiation and modulation of the atherosclerotic process. Through the approaches of gene manipulation in the mouse model, a substantial body of literature has accumulated that depicts scavenger receptor class A as a central player in atherogenesis. In studies of scavenger receptor class A overexpression in macrophages through bone marrow transplantation using transgenic donor material, recipient mice with hyperlipidemia caused either by apolipoprotein E or LDL receptor deficiency did not show convincing changes in the degree of atherosclerosis development compared with controls. Conversely, the deletion of the scavenger receptor class A gene in the mouse has shown, in a consistent and significant fashion, that this receptor serves a pro-atherogenic function under hyperlipidemic conditions, as both apolipoprotein E and LDL receptor-deficient mice had reduced atherosclerosis in the absence of scavenger receptor class A. In addition, we have recently shown that C57BL/6 mice are protected from diet-induced atherosclerosis when they lack scavenger receptor class A, and that the macrophage is the cell type responsible for the effect of scavenger receptor class A deficiency in reducing lesion formation in C57BL/6 and LDL receptor null mice. Together, these results demonstrate that macrophage scavenger receptor class A contributes significantly to atherosclerotic lesion formation, and suggest that the uptake of oxidized or modified lipoproteins by vessel wall macrophages is a central process in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561167     DOI: 10.1097/00041433-200110000-00003

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  27 in total

1.  Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis.

Authors:  Tanu Goyal; Sona Mitra; Magomed Khaidakov; Xianwei Wang; Sandeep Singla; Zufeng Ding; Shijie Liu; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2012-01-29       Impact factor: 5.113

2.  High fat diet containing cholesterol induce aortic aneurysm through recruitment and proliferation of circulating agranulocytes in apoE knock out mice model.

Authors:  K Gopal; Kishor Kumar; R Nandini; P Jahan; M J Mahesh Kumar
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

3.  18F-FDG PET/CT imaging in tendon xanthomatosis.

Authors:  Dae-Weung Kim; Chang-Guhn Kim; Soon-Ah Park; Young Cheon Na
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-20       Impact factor: 9.236

Review 4.  Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases.

Authors:  Kieran Quinn; Melanie Henriques; Tom Parker; Arthur S Slutsky; Haibo Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-19       Impact factor: 4.733

Review 5.  A lipidomic perspective on inflammatory macrophage eicosanoid signaling.

Authors:  Paul C Norris; Edward A Dennis
Journal:  Adv Biol Regul       Date:  2013-09-25

Review 6.  Emerging diagnostic and therapeutic molecular imaging applications in vascular disease.

Authors:  Luis H Eraso; Muredach P Reilly; Chandra Sehgal; Emile R Mohler
Journal:  Vasc Med       Date:  2011-02-10       Impact factor: 3.239

7.  Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.

Authors:  Björn Gustafsson; Susan Youens; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

8.  The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice.

Authors:  Andrea Mencarelli; Sabrina Cipriani; Barbara Renga; Daniela Francisci; Giuseppe Palladino; Eleonora Distrutti; Franco Baldelli; Stefano Fiorucci
Journal:  PLoS One       Date:  2010-10-08       Impact factor: 3.240

9.  Increased CD36 protein as a response to defective insulin signaling in macrophages.

Authors:  Chien-Ping Liang; Seongah Han; Haruka Okamoto; Ronald Carnemolla; Ira Tabas; Domenico Accili; Alan R Tall
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

10.  N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.

Authors:  Khaled A Ahmed; Sekaran Muniandy; Ikram S Ismail
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.